Lv7
4960 积分 2024-06-26 加入
Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer
3天前
已完结
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial
3天前
已完结
PL03.10 Adjuvant Chemotherapy (CT) vs CT-immunotherapy for R0 Stage IB-IIIA NSCLC Patients (NADIM ADJUVANT): a Randomized, Phase 3 Trial
5天前
已关闭
Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer
5天前
已完结
Chinese expert consensus on perioperative management of patients with resectable anaplastic lymphoma kinase-fusion non–small cell lung cancer
7天前
已完结
Neoadjuvant immunotherapy in early-stage NSCLC: navigating biomarker dilemmas and special population challenges
7天前
已完结
Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT
7天前
已完结
Predictive Capability of PD-L1 Protein Expression for Patients With Advanced NSCLC: Any Differences Based on Histology?
25天前
已完结
Daraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer
1个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
1个月前
已完结